Healthcare

Could Institutional Investors Influence GSK plc (LON:GSK) After a No...

Highlights,Institutional ownership of GSK plc,(LON:GSK),stands at 86%, making it highly sensitive to their trading decisions.,A small group of 23 inst...

Oncimmune Holdings PLC Transforms Its Biopharma Strategy Amid Financ...

Oncimmune Holdings PLC Transforms Its Biopharma Strategy Amid Financial and Operational Shifts

Could Artemis Uncover Hidden Gold Reserves in the Pilbara?

Could Artemis Uncover Hidden Gold Reserves in the Pilbara?

Cardiogeni (AQSE: CGNI) Signs Memorandum of Understanding with UAE P...

Highlights,Cardiogeni secures £20 million funding for heart failure clinical trials in UAE.,Joint venture with UAE Private Office to develop medicines...

Could Faron's New Fundraising Boost Breakthroughs in Cancer Therapy?

Could Faron's New Fundraising Boost Breakthroughs in Cancer Therapy?

Biotechnology Sector: Oncimmune's Strategic Growth and Industry Lead...

In Case You Missed It: Insights from Oncimmune's CEO on Projected 2025 Growth and Upcoming Deals

Could This Breakthrough in DNA Analysis Transform Liquid Biopsies?

Could This Breakthrough in DNA Analysis Transform Liquid Biopsies?

Faron Pharmaceuticals (AIM:FARN) Strategic Funding and Clinical Prog...

Faron Pharmaceuticals (AIM:FARN) Strategic Funding and Clinical Progress in Cancer Immunotherapy

AstraZeneca (LSE:AZN) Navigating Regulatory Challenges and Strategic...

AstraZeneca (LSE:AZN) Navigating Regulatory Challenges and Strategic Growth in Pharma

AstraZeneca Reports 21% Revenue Growth in FY24, Driven by 19% Rise i...

Highlights,Revenue Surge:,AstraZeneca’s total revenue rose by,21%,to,$54.1 billion,, led by,19% growth in product sales,and continued momentum in part...

STERIS (NYSE:STE) Sees 42% Growth Over Five Years Despite Recent Dec...

Highlights,Share Price Rises Over Five Years,STERIS (STE) recorded a 42% increase over the past five years, reflecting steady growth.,Recent Performan...

Oxford BioDynamics (AIM: OBD) Announces Breakthrough Colorectal Canc...

Highlights,EpiSwitch® 3D genomics platform demonstrates 81% accuracy for early-stage CRC detection.,Non-cancerous polyps identified with 82% accuracy...

Bioventix (LON:BVXP) Stock Drops Below Two-Hundred-Day Moving Averag...

Bioventix (BVXP) saw its stock price dip below the two-hundred-day moving average.,The stock traded as low as GBX 3,051, signaling a shift in its pric...

RUA Life Sciences Delivers Positive Performance from ABISS French Su...

Highlights:,Revenue Growth:,ABISS achieved €2.3 million in revenue for the year to December 2024, marking a 7% increase over 2023.,Profit Turnaround:,...

Alliance Pharma Reports Stable Revenues in 2024 Trading Update

Highlights,Total revenues for 2024 reached £180.3 million, marking a 1% YoY decline but a 1% increase at constant exchange rates (CER).,Consumer healt...

CSL Limited (ASX:CSL) Analyzing 5-Year Earnings Growth Amidst Share...

Highlights,CSL’s share price dropped 13% over five years despite steady earnings growth.,The company's earnings per share (EPS) increased by 5.2% annu...

CVS Group Reports 6.6% Increase in Sales for H1 2025 Amid Market Cha...

Highlights,Sales Growth:,Group sales up 6.6%, totaling £341.8m for H1 2025.,Adjusted EBITDA:,Increased by 4.5% to £67.4m, with an EBITDA margin of 19....

hVIVO Acquires Two Clinical Research Units in €10M Deal to Expand Eu...

Highlights,hVIVO acquires two German clinical research units,from CRS for,€10 million,in cash.,Expands services to include Phase I and II trials,acros...

ImmuPharma (LON:IMM) Trading Up 9.3%: Positive Movement in Specialty...

Highlights,ImmuPharma's (IMM) share price surged by 9.3% on Saturday.,The company saw significant trading volume with a 60% increase from average dail...

Hikma Pharmaceuticals (LON:HIK) Hits New 52-Week High Amid Positive...

Highlights,Hikma Pharmaceuticals reaches a new 52-week high, signaling strong market performance.,Stock shows impressive growth with a significant inc...